126 results on '"Wejksza, Katarzyna"'
Search Results
2. Supplementary Figure 5 from Tumor-Evoked Regulatory B Cells Promote Breast Cancer Metastasis by Converting Resting CD4+ T Cells to T-Regulatory Cells
3. Supplementary Figure 2 from Tumor-Evoked Regulatory B Cells Promote Breast Cancer Metastasis by Converting Resting CD4+ T Cells to T-Regulatory Cells
4. Data from Tumor-Evoked Regulatory B Cells Promote Breast Cancer Metastasis by Converting Resting CD4+ T Cells to T-Regulatory Cells
5. Supplementary Figure 7 from Tumor-Evoked Regulatory B Cells Promote Breast Cancer Metastasis by Converting Resting CD4+ T Cells to T-Regulatory Cells
6. Supplementary Figure 8 from Tumor-Evoked Regulatory B Cells Promote Breast Cancer Metastasis by Converting Resting CD4+ T Cells to T-Regulatory Cells
7. Supplementary Figure 2 from Anti-CD20 Antibody Promotes Cancer Escape via Enrichment of Tumor-Evoked Regulatory B Cells Expressing Low Levels of CD20 and CD137L
8. Supplementary Figure 3 from Anti-CD20 Antibody Promotes Cancer Escape via Enrichment of Tumor-Evoked Regulatory B Cells Expressing Low Levels of CD20 and CD137L
9. Supplementary Figure 5 from Anti-CD20 Antibody Promotes Cancer Escape via Enrichment of Tumor-Evoked Regulatory B Cells Expressing Low Levels of CD20 and CD137L
10. Supplementary Figure 3 from Tumor-Evoked Regulatory B Cells Promote Breast Cancer Metastasis by Converting Resting CD4+ T Cells to T-Regulatory Cells
11. Supplementary Figure 1 from Tumor-Evoked Regulatory B Cells Promote Breast Cancer Metastasis by Converting Resting CD4+ T Cells to T-Regulatory Cells
12. Data from Anti-CD20 Antibody Promotes Cancer Escape via Enrichment of Tumor-Evoked Regulatory B Cells Expressing Low Levels of CD20 and CD137L
13. Supplementary Figure 4 from Anti-CD20 Antibody Promotes Cancer Escape via Enrichment of Tumor-Evoked Regulatory B Cells Expressing Low Levels of CD20 and CD137L
14. Supplementary Figure 4 from Tumor-Evoked Regulatory B Cells Promote Breast Cancer Metastasis by Converting Resting CD4+ T Cells to T-Regulatory Cells
15. Supplementary Figure 6 from Anti-CD20 Antibody Promotes Cancer Escape via Enrichment of Tumor-Evoked Regulatory B Cells Expressing Low Levels of CD20 and CD137L
16. Supplementary Figure Legend from Anti-CD20 Antibody Promotes Cancer Escape via Enrichment of Tumor-Evoked Regulatory B Cells Expressing Low Levels of CD20 and CD137L
17. Supplementary Figure 6 from Tumor-Evoked Regulatory B Cells Promote Breast Cancer Metastasis by Converting Resting CD4+ T Cells to T-Regulatory Cells
18. Supplementary Methods, Figure Legends 1-8 from Tumor-Evoked Regulatory B Cells Promote Breast Cancer Metastasis by Converting Resting CD4+ T Cells to T-Regulatory Cells
19. Supplementary Figure 1 from Anti-CD20 Antibody Promotes Cancer Escape via Enrichment of Tumor-Evoked Regulatory B Cells Expressing Low Levels of CD20 and CD137L
20. Łagodna hiperhomocysteinemia u chorych z nadpłytkowością samoistną (NS), związek z mutacją genu MTHFR i poziomem kwasu foliowego
21. Kynurenic acid in blood and bone marrow plasma of monoclonal gammopathy of undetermined significance (MGUS) and multiple myeloma (MM) patients
22. Beneficial impact of cathelicidin on hypersensitivity pneumonitis treatment—In vivo studies
23. Kynurenic acid protects against the homocysteine-induced impairment of endothelial cells
24. Betulinic acid decreases expression of bcl-2 and cyclin D1, inhibits proliferation, migration and induces apoptosis in cancer cells
25. Demonstration of Kynurenine Aminotransferases I and II and Characterization of Kynurenic Acid Synthesis in Oligodendrocyte Cell Line (OLN-93)
26. Effect of Oxidative Stress on the Junctional Proteins of Cultured Cerebral Endothelial Cells
27. Kynurenic acid production in cultured bovine aortic endothelial cells. Homocysteine is a potent inhibitor
28. Ammonia at pathophysiologically relevant concentrations activates kynurenic acid synthesis in cultured astrocytes and neurons
29. Effect of Oxidative Stress on the Junctional Proteins of Cultured Cerebral Endothelial Cells
30. Colon cancer–derived conditioned medium induces differentiation of THP-1 monocytes into a mixed population of M1/M2 cells
31. Riluzole Inhibits Proliferation, Migration and Cell Cycle Progression and Induces Apoptosis in Tumor Cells of Various Origins
32. Tumor-Associated Macrophages as Target for Antitumor Therapy
33. A King Bolete, Boletus edulis (Agaricomycetes), RNA Fraction Stimulates Proliferation and Cytotoxicity of Natural Killer Cells Against Myelogenous Leukemia Cells
34. Cancer-produced metabolites of 5-lipoxygenase induce tumor-evoked Bregs via peroxisome proliferator-activated receptor alpha
35. Wtórne nowotwory u chorych z nadpłytkowością samoistną leczonych w Klinice Hematoonkologii i Transplantacji Szpiku UM w Lublinie
36. Inhibition of Breast Cancer Metastasis by Resveratrol-Mediated Inactivation of Tumor-Evoked Regulatory B Cells
37. Inhibition of Lung Metastasis by Chemokine CCL17-mediated In Vivo Silencing of Genes in CCR4+ Tregs
38. Anti-CD20 Antibody Promotes Cancer Escape via Enrichment of Tumor-Evoked Regulatory B Cells Expressing Low Levels of CD20 and CD137L
39. Cancer-Produced Metabolites of 5-Lipoxygenase Induce Tumor-Evoked Regulatory B Cells via Peroxisome Proliferator–Activated Receptor α
40. Resveratrol abrogates tumor-evoked Bregs conversion by targeting PPAR-alpha pathway (127.41)
41. Failure of Rituximab in solid tumors is due to its inability to eliminate tumor evoked B regulatory cells (165.15)
42. JAK2 mutation status, hemostatic risk factors and thrombophilic factors in essential thrombocythemia (ET) patients
43. Thymic Stromal Lymphopoietin Is a Key Mediator of Breast Cancer Progression
44. Tumor-Evoked Regulatory B Cells Promote Breast Cancer Metastasis by Converting Resting CD4+ T Cells to T-Regulatory Cells
45. Thymic stromal lymphopoietin mediates breast cancer progression and metastasis (48.9)
46. Tumor-induced regulatory B cells promote cancer metastasis by inducing generation of FoxP3+ regulatory T cells (66.16)
47. Kynurenic acid protects against the homo-cysteine-induced impairment of endothelial cells
48. JAK2 Mutational Status, Hemostatic Risk Factors and Thrombophilic Factors in Essential Thrombocythemia (ET) Patients
49. Fibrinolytic Activity in Patients with Essential Thrombocythemia.
50. Demonstration of kynurenine aminotransferases I and II and characterization of kynurenic acid synthesis in cultured cerebral cortical neurons
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.